<< Back
Discovery on Target – “Targeting Epigenetic Readers”
Aurigene to participate in “Targeting Epigenetic Readers” Conference to be held in Boston, MA.
Dr. Hosahalli Subramanya (Senior Vice President, Structural Biology & Lead Generation, Aurigene) will speak about “Identification of Potent, BET Bromodomain Inhibitors for Treatment of Cancers” in the session- Therapeutic Applications of inhibiting Bet bromodomains of the conference.
Conference link: https://www.discoveryontarget.com/Epigenetic-Readers/